ストックスクリーナーアプリを入手
2.49
0.80%
-0.02
前日終値:
$2.51
開ける：
$2.47
24時間の取引高:
94,583
Relative Volume:
0.70
時価総額：
$72.17M
収益：
-
当期純損益:
$-75.52M
株価収益率:
-0.8646
EPS:
-2.88
ネットキャッシュフロー:
$-56.92M
1週間 パフォーマンス:
-1.58%
1か月 パフォーマンス:
+2.89%
6か月 パフォーマンス:
+21.46%
1年 パフォーマンス:
-91.44%
1日の値動き範囲:
$2.45
$2.575
1週間の範囲:
$2.45
$2.575
52週間の値動き範囲:
$1.25
$28.70
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
AVTE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVTE
Aerovate Therapeutics Inc
|
2.49 | 72.17M | 0 | -75.52M | -56.92M | -2.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-18 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-06-18 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-06-18 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-06-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-17 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-03-25 | 再開されました | Jefferies | Buy |
| 2023-12-08 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2022-12-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-08-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-02-11 | 開始されました | BTIG Research | Buy |
| 2021-07-26 | 開始されました | Cowen | Outperform |
| 2021-07-26 | 開始されました | Evercore ISI | Outperform |
| 2021-07-26 | 開始されました | Jefferies | Buy |
| 2021-07-26 | 開始されました | Wedbush | Outperform |
すべてを表示
Aerovate Therapeutics Inc (AVTE) 最新ニュース
36,897 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Acquired by Corient Private Wealth LLC - Defense World
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AMPY, HEES, AVTE, TGI to Act Now - GlobeNewswire Inc.
Aerovate Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aerovate Therapeutics Inc. (AVTE) reports earnings - Quartz
Aerovate Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, PTMN, AVTE on Behalf of Shareholders - The Malaysian Reserve
Aerovate Therapeutics (AVTE) Expected to Announce Quarterly Earnings on Monday - Defense World
FY2029 Earnings Estimate for AVTE Issued By Wedbush - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders - ACCESS Newswire
FY2029 Earnings Forecast for AVTE Issued By Wedbush - Defense World
In Another Blow to Delaware's Hegemony Another Company Proposes Reincorporation in Nevada - The National Law Review
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCCNE, LGTY, AVTE, PLYA - Longview News-Journal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders - Stockhouse Publishing
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Increase in Short Interest - MarketBeat
Ready to Jump After Recent Trade: Aerovate Therapeutics Inc (AVTE) - SETE News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders - EIN News
Deltec Asset Management LLC Invests $514,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Growth in Short Interest - MarketBeat
Barclays PLC Raises Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MHLD, IPG, AVTE on Behalf of Shareholders - GlobeNewswire
Aerovate Therapeutics Target of Unusually Large Options Trading (NASDAQ:AVTE) - MarketBeat
Jane Street Group LLC Trims Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Jane Street Group LLC Trims Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Increases By 35.5% - MarketBeat
Unusually active option classes on open January 16th - TipRanks
Geode Capital Management LLC Sells 25,287 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Barclays PLC Has $39,000 Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
State Street Corp Raises Stock Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders - The Eastern Progress Online
Fmr LLC Boosts Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Charles Schwab Investment Management Inc. Reduces Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerAVTE, BCOV, ALVR, AE - cnhinews.com
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - Defense World
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 5.3% in November - MarketBeat
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - The Eastern Progress Online
Verition Fund Management LLC Sells 149,137 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Pulmonary Arterial Hypertension Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen Pharma, Aerovate - The Globe and Mail
Aerovate Therapeutics Inc (AVTE) 財務データ
収益
当期純利益
現金流量
EPS
3.01%
大文字化:
|
ボリューム (24 時間):